Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Scientific to Commence Trading on Nasdaq
Effective Tuesday, September 28, 2021 SANTA CLARA, Calif. , Sept. 27, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that The Nasdaq Stock Market
View HTML
Toggle Summary Semler Scientific to Present at Upcoming Investor Conferences
SANTA CLARA, Calif. , Aug. 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that Chief Executive Officer Doug Murphy-Chutorian , M.D.
View HTML
Toggle Summary Semler Reports Second Quarter and First Half of 2021 Financial Results
2021 Q2 HIGHLIGHTS compared to the corresponding period of 2020: - Revenues were $14.3 million, an increase of 125% compared to $6.4 million - Pre-tax net income of $6.5 million, an increase of $5.5 million, or 554%, compared to $1.0 million - Net income was $6.7 million, or $1.00 per basic share
View HTML
Toggle Summary Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021
SANTA CLARA, Calif. , July 21, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and
View HTML
Toggle Summary Semler to Participate in the Raymond James Human Health Innovation Conference
SANTA CLARA, Calif. , June 10, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief
View HTML
Toggle Summary Semler Reports First Quarter 2021 Financial Results
2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: - Revenues were $13.2 million, an increase of 40% - Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million - Net income was $4.9 million, or $0.73 per basic share and $0.60 per diluted share,
View HTML
Toggle Summary Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021
SANTA CLARA, Calif. , April 26, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended
View HTML
Toggle Summary Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif. , April 7, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief
View HTML
Toggle Summary Semler Reports Record Fourth Quarter and Year End 2020 Financial Results
2020 HIGHLIGHTS compared to 2019: - Annual revenues increased by 18% - Pre-tax net income of $16.5 million, an increase of $5.8 million, or 54%, compared to $10.7 million - Net income of $14.0 million, a decrease of $1.1 million, or 7%, compared to $15.1 million (which included a $4.4 million
View HTML
Toggle Summary Semler to Participate in the H.C. Wainwright Global Life Sciences Conference
SANTA CLARA, Calif. , Feb. 25, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief
View HTML

Semler Scientific

Contact us
Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051

Call us toll-free at
877-774-4211